GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya.

GSK said that IDRX-42 addresses all the key KIT mutations that drive tumour growth and progression in GIST, which is estimated to affect between 4,000 and 6,000 people in the US each year.

GSK PLC Annual cash flow by MarketWatch. View GSK net cash flow, operating cash flow, operating expenses and cash dividends.

NAQI (National Air Quality Index) is tool that uses numbers to simplify air quality data by classifying pollution levels into 6 categories - good, satisfactory, moderate, poor, very poor and severe, ...